XML 23 R5.htm IDEA: XBRL DOCUMENT v3.20.2
STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Shares
Additional paid in capital
Accumulated Deficit
Beginning Balance at Jun. 30, 2017 $ 50,838 $ 36,772 $ 225,169 $ (174,331)
Net loss (40,068)     (40,068)
Issuance of common stock in private placement, net (Note 8) 35,910 33,003 35,910  
Issuance of common stock for milestone payment, net (Note 10) 500 167 500  
Issuance of common stock for vested restricted stock units (267) 271 (267)  
Exercise of stock options 329 193 329  
Share-based compensation expense 3,217   3,217  
Ending Balance at Jun. 30, 2018 50,459 70,406 264,858 (214,399)
Net loss (16,819) [1]     (16,819)
Issuance of common stock, net 5,444 2,215 5,444  
Exercise of warrants 2,186 440 2,186  
Issuance of common stock for vested restricted stock units (324) 246 (324)  
Exercise of stock options 422 238 422  
Share-based compensation expense 6,562   6,562  
Ending Balance at Jun. 30, 2019 47,930 73,545 279,148 (231,218)
Net loss (46,016) [1]     (46,016)
Issuance of common stock, net 69,231 37,815 69,231  
Exercise of stock options 272 154 272  
Share-based compensation expense 6,801   6,801  
Ending Balance at Jun. 30, 2020 $ 78,218 $ 111,514 $ 355,452 $ (277,234)
[1] We have experienced large changes in our net loss which relates to the change in fair value of the warrant liability for the years ended June 30, 2020 and 2019. Refer to Note 1 for further discussion.